共 50 条
- [1] Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research InstituteCANCER MEDICINE, 2015, 4 (05): : 673 - 681Hainsworth, John D.Thompson, Dana S.Bismayer, John A.Gian, Victor G.Merritt, William M.Whorf, Robert C.Finney, Lindsey H.Dudley, B. Stephens
- [2] Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: A randomized phase II study of the Sarah Cannon Research InstituteJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Thompson, Dana SheltonDudley, B. StephensBismayer, John A.Gian, Victor G.Merritt, William McIverWhorf, Robert C.Burris, Howard A.Hainsworth, John D.
- [3] Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IVGYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 236 - 240Meier, Wernerdu Bois, AndreasRau, JoernGropp-Meier, MartinaBaumann, KlausHuober, JensWollschlaeger, KerstinKreienberg, RolfCanzler, UlrichSchmalfeldt, BarbaraWimberger, PaulineRichter, BarbaraSchroeder, WillibaldBelau, AntjeStaehle, AnneBurges, AlexanderSehouli, Jalid
- [4] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized studyEUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912Bolis, GiorgioScarfone, GiovannaRaspagliesi, FrancescoMangili, GiorgiaDanese, SaverioScollo, PaoloLo Russo, DomenicaVilla, AntonellaAimone, Paola DanielaScambia, Giovanni
- [5] The combination of paclitaxel and carboplatin as first-line chemotherapy in patients with stage III and stage IV ovarian cancer - A phase I-II studyAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05): : 491 - 497Zamagni, CMartoni, ACacciari, NGentile, APannuti, F
- [6] Paclitaxel and carboplatin as outpatient therapy for stage III and IV epithelial ovarian cancerPANMINERVA MEDICA, 2001, 43 (04) : 263 - 265Balbi, GCMenditto, ACalabria, GMusone, RDi Prisco, LCassese, EBalbi, CCardone, A
- [7] Phase I/II lapatinib plus carboplatin and paclitaxel in stage III or IV relapsed ovarian cancer patientsJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Rivkin, S. E.Muller, C.Iriarte, D.Arthur, J.Canoy, A.Reid, H.
- [8] A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancerJAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (04) : 128 - 134Yamamoto, RMinobe, SKaneuchi, MSakuragi, NFujimoto, SIshizaki, YDomon, HHareyama, HSato, CFujino, TKawaguchi, IYamaguchi, TFujimoto, TYoshiaki, K
- [9] Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancerJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2674 - 2682Lhomme, CatherineJoly, FlorenceWalker, Joan L.Lissoni, Andrea A.Nicoletto, Maria O.Manikhas, Gregory M.Baekelandt, Mark M. O.Gordon, Alan N.Fracasso, Paula M.Mietlowski, William L.Jones, Gary J.Dugan, Margaret H.
- [10] Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian CancerJOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4162 - 4169du Bois, AndreasHerrstedt, JornHardy-Bessard, Anne-ClaireMueller, Hans-HelgeHarter, PhilippKristensen, GunnarJoly, FlorenceHuober, JensAvall-Lundqvist, ElisabethWeber, BeatriceKurzeder, ChristianJelic, SvetislavPujade-Lauraine, EricBurges, AlexanderPfisterer, JacobusGropp, MartinaStaehle, AnneWimberger, PaulineJackisch, ChristianSehouli, Jalid